Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-10-06
1998-03-31
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
604 50, 604 52, 607 3, A61K 3842, A61N 139
Patent
active
057338698
ABSTRACT:
Administration of stroma-free crosslinked hemoglobin during standard cardiac pulmonary resuscitation procedures enhances return of spontaneous circulation following electrical defibrillation. The difficulty in restoring spontaneous circulation directly correlates with a generally poor prognosis in cases of cardiac arrest. The therapeutic effect of hemoglobin as an adjunct to conventional treatment may thereby improve survival.
REFERENCES:
patent: Re34271 (1993-06-01), Walder
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4336248 (1982-06-01), Bonhard et al.
patent: 4529719 (1985-07-01), Tye
patent: 4598064 (1986-07-01), Walder
patent: 4600531 (1986-07-01), Walder
patent: 4757052 (1988-07-01), Markov
patent: 4826811 (1989-05-01), Sehgal et al.
patent: 4866096 (1989-09-01), Schweighardt
patent: 4873230 (1989-10-01), Belzer et al.
patent: 4988515 (1991-01-01), Buckberg
patent: 4994444 (1991-02-01), Zikria
patent: 5084558 (1992-01-01), Rausch et al.
patent: 5194590 (1993-03-01), Sehgal et al.
patent: 5248785 (1993-09-01), Abraham et al.
patent: 5268500 (1993-12-01), Lalezari et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5306508 (1994-04-01), Kossovsky et al.
patent: 5334706 (1994-08-01), Przybelski
patent: 5370870 (1994-12-01), Wong
patent: 5386014 (1995-01-01), Nho et al.
patent: 5413558 (1995-05-01), Paradis
patent: 5428007 (1995-06-01), Fischer et al.
patent: 5432191 (1995-07-01), Abraham et al.
patent: 5464814 (1995-11-01), Sehgal et al.
patent: 5510464 (1996-04-01), Przybelski
Emergency Cardiac Care Committee and Subcommitess, American Heart Assoc. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care, II: Adult Basic Life Support. JAMA. 1992. vol. 268, pp. 2184-2198.
Cole et al, Effect of Oncotic Pressure of Diaspirin Cross-Linked . . . Anesth. Analg. vol. 83, pp. 342-347, 1996.
Linz et al, Diaspirin Crosslinked Hemoglobin Infusion . . . FASEB J. vol. 9, No. 3, p. A9, Abstract No. 54, 1995.
Cocks et al, Oxyhaemoglobin Increases The Production of . . . Eur. J. Pharmac. vol. 196, pp. 177-182, 1991.
Riess, Fluorocarbon-Based in Vivo Oxygen Transport . . . Vox Sang. vol. 61, pp. 225-239, 1991.
Rosenkranz et al, Warm Induction of Carioplegia With . . . J. Thorac. Cardiovasc. Surg. vol. 86, pp. 507-518, 1983.
Amberson et al., Clinical Experience with Hemoglobin-Saline Solutions, Physiology, vol. 1, No. 7, pp. 469-489, 1949.
Amberson et al., On the Use of Ringer Locke Solutions Containing Hemoglobin as a Substitute for Normal Blood in Mammals, Journal of Cellular and Comparative Physiology, vol. 5, pp. 359-382, 1934.
American Heart Association, Advanced Cardiac Life Support Algorithms and Drugs: A 1993 Handbook for Adult and Pediatric Providers, JAMA, vol. 268, pp. 2199-2241, 1992.
Biro et al., Coronary Vascular Actions of Stroma-Free Hemoglobin Preparations, Artificial Organs, vol. 12, No. 1, pp. 40-50, 1988.
Biro et al., The Effect of Hemodilution with Stroma-Free Hemoglobin and Dextran on Collateral Perfusion of Ischemic Myocardium in the Dog, American Heart Journal, vol. 99, No. 1, pp. 64-75, 1980.
Bleske et al., Effects of Different Dosages and Modes of Sodium Bicarbonate Administration During Cardiopulmonary Resuscitation, American Journal of Emergency Medicine, vol. 10, No. 6, pp. 525-532, 1992.
Block et al., Morphology After Transluminal Angioplasty in Human Beings, The New England Journal of Medicine, vol. 305, No. 7, pp. 382-385, 1981.
Bowes et al., Diaspirin Cross-Linked Hemogolbin Improves Neurological Outcome Following Reversible but Not Irreversible CNS Ischemia in Rabbits, Chemical Abstracts, vol. 122, No. 13, Abstract No. 151066q, pp. 45-46, 1995.
Capparelli et al., Differences in Systematic and Myocardial Blood Acid-Base Status During Cardiopulmonary resuscitation, Critical Care Medicine, vol. 17, No. 5, pp. 442-446, 1989.
Capparelli et al., Diltiazem Improves Resuscitation from Experimental Ventricular Fibrillation in Dogs, Critical Care Medicine, vol. 20, No. 8, pp. 1140-1145, 1992.
Chow et al., Beneficial Effects of Diaspirin Cross-Linked Hemoglobin During Fibrillatory Arrest and CPR in an Animal Model, Circulation, vol. 92, No. 8, p. 833, 1995.
Chow et al., Effect of Exernal Cardiopulmonary Resuscitation on Lidocaine Pharmacokinetics in Dogs, The Journal of Pharmacology and Experimental Therapeutics, vol. 224, No. 3, pp. 531-537, 1983.
Coetzee et al., Halothane and the Reperfusion Injury in the Intact Animal Model, Anesth. Analg., vol. 76, No. 4, pp. 734-744, 1993.
Cole et al., Focal Cerebral Ischemia in Rats: Effect of Hemodilution with x-x Cross-Linked Hemoglobin on CBF, Journal of Cerebral Blood Flow & Metabolism, vol. 12, No. 6, pp. 971-976, 1992.
Cole et al., Focal Cerebral Ischemia in Rats: Effect of Hemodilution with x-x Cross-Linked Hemoglobin on Brain Injury and Edema, The Canadian Journal of Neurological Sciences, vol. 20, No. 1, pp. 30-36, 1993.
Cole et al., Focal Cerebral Ischemia in Rats: Effect of Hypervolemic Hemodilution with Diaspirin Cross-Linked Hemoglobin Versus Albumin on Brain Injury and Edema, Anesthesiology, vol. 78, No. 2, pp. 335-342, 1993.
Cole et al., Focal Cerebral Ischemia: Effects of Oncotic Pressure of a Molecular Hemoglobin Preparation on Infarct Volume in Rats, Anesth. Analog, vol. 80, No. S82, 1995.
Cole et al., Hemodilution during Cerebral Ischemia in Rats: Effects of Stroma-Free Hemoglobin on Brain Injury, Anseth. Analog, vol. 74, Abstract S50, 1992.
Cole et al., The Effect of Molecular Hemoglobin's Nitric Oxide Binding Properties, Anesth. Analog, vol. 80, No. S83, 1995.
Elger et al., Magnetic Resonance Imaging Study on the Effect of Levemopamil on the Size of Intracerebral Hemorrhage in Rats, Stroke, vol. 25, No. 9, pp. 1836-1841, 1994.
Estep, Efficacy and Safety of a Diaspirin Modified Hemoglobin Solution, ISBT Presentation, 1988.
Feola et al., Improved Oxygenation of Ischemic Myocardium by Hemodilution with Stroma-Free Hemoglobin Solution, Chest, vol. 75, No. 3, pp. 369-375, 1979.
Foley et al., Cytotoxic Effects of Bloody Cerebrospinal Fluid on Cerebral Endothelial Cells in Culture, Journal of Neurosurgery, vol. 81, pp. 87-92, 1994.
Forster et al., The Use of Stroma-Free Hemoglobin Solutions as Blood Substitute, Infusionsther Klin Ernahr., vol. 4, No. 2, pp. 122-126, (abstract), 1977.
Greenburg et al., Intravascular Persistence and Oxygen Delivery of Pyridoxalated, Stroma-Free Hemoglobin During Gradations of Hypotension, Surgery, vol. 86, No. 1, pp. 13-16, 1979 (abstract only).
Grotta, A Glimpse to the Future: Multitherapy Trials, Cerebrovasc. Dis., vol. 5, Suppl. 1, pp. 27-30, 1995.
Halstenson et al., Pharmacologic Profile of Diaspirin Cross-linked Hemoglobin (DCLHb) in Hemodialysis (HD) Patients, Journal of American Society of Nephrology, vol. 5, No. 3, Abstract 84P, pp. 451, 1994.
Hariman et al., Regional Changes in Blood Flow, Extracellular Potassium and Conduction During Myocardial Ischemia and Reperfusion, JACC, vol. 21, No. 1, pp. 798-808, 1993.
Hauck et al., Intracoronary Diaspirin Crosslinked Hemoglobin (DCLHb) Infusion During Coronary Balloon Occlusion in Dogs and Pigs, ABSTRACT-Biomaterials, Artificial Cells, and Immobilization Biotechnology, vol. 19, No. 2, 1991.
Jakobsen, Brain Ischemia In Subarachnoid Hemorrhage, pp. 3-32, 1992.
Jan et al., Coronary Hemodynamics and Oxygen Utilization After Hematocrit Variations in Hemorrhage, Am. J. Physiol., vol. 239, pp. H326-H332, 1980.
Jennings et al., Reperfusion Injury, Definitions and Historical Background, Myocardial Protection: the Pathophysiology of Reperfusion and Reperfusion Injury, pp. 1-11, 1992.
Jeroudi et al., Myocardial Reperfusion Injury: Role of Oxygen Radicals and Potential Therapy with Antioxidants, The American Journal of Cardiology, vol. 73, pp. 2B-7B, 1994.
Kim et al., Effects of Hemoglobin Perfusion of Contractile Function of the Isolated Ventricular Septa, Biomat. Art. Cells, Art. Org., vol. 16, Nos. 1-3, 331-345, 1988.
Kim et al., Effects of Hemoglobin Perfusion on Contractile Function of the Isolated Ventricular Septa, Chemical Abstracts, vol. 109, No. 21, Abstract N
Burhop Kenneth E.
Chow Moses S. S.
Baxter International Inc.
Russel Jeffrey E.
LandOfFree
Therapeutic administration of hemoglobin in cardiac arrest does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic administration of hemoglobin in cardiac arrest, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic administration of hemoglobin in cardiac arrest will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-51849